Form 4: Novavax Director James F. Young Sells 7,500 Shares
SEC Form 4
Director James F. Young sold 7,500 shares of Novavax Inc. at $14.09 per share on June 21, 2024.
Summary
- On June 21, 2024, James F. Young, a director of Novavax Inc., sold 7,500 shares of common stock.
- The sale price was $14.09 per share.
- Following the transaction, Young directly owns 61,760 shares of Novavax common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock sale by a director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a routine disclosure of a stock transaction by a company insider. It's common for directors and officers to buy and sell shares of their company's stock, and these transactions are closely monitored by regulators and investors.
Stakeholder Impact
- The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and the director's reasons for selling.
Key Dates
| Date | Description |
|---|---|
| 06/21/2024 | Date of transaction: James F. Young sold 7,500 shares of Novavax stock. |
| 06/25/2024 | Date of signature by Mark J. Casey, Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.